Literature DB >> 16051905

Family caregiver research and the HIPAA factor.

Steven M Albert1, Carol Levine.   

Abstract

Research in family caregiving recently has become more challenging because of the strict protection of privacy mandated in the Health Insurance Portability and Accountability Act (HIPAA) of 1996. We ask when should Institutional Review Boards (IRBs) follow HIPAA rules to the letter and when might they use the waiver option? What is the appropriate balance between the goals of protecting the privacy of patients' personal health information and facilitating family-caregiver research that may benefit them and others? More particularly, should patients be gatekeepers for caregiver participation in minimal-risk research? We describe one approach that successfully met HIPAA criteria and also allowed high-quality research. In developing protocols and applying for IRB approval, researchers must be as familiar with HIPAA regulations as they are with IRB standards. Finally, we recommend changes in the review process that may facilitate research efforts with family caregivers while protecting important privacy interests.

Entities:  

Mesh:

Year:  2005        PMID: 16051905     DOI: 10.1093/geront/45.4.432

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  3 in total

1.  The impact of HIPAA authorization on willingness to participate in clinical research.

Authors:  Anne L Dunlop; Tracie Graham; Zanie Leroy; Karen Glanz; Boadie Dunlop
Journal:  Ann Epidemiol       Date:  2007-08-06       Impact factor: 3.797

2.  "This case is closed": family caregivers and the termination of home health care services for stroke patients.

Authors:  Carol Levine; Steven M Albert; Alene Hokenstad; Deborah E Halper; Andrea Y Hart; David A Gould
Journal:  Milbank Q       Date:  2006       Impact factor: 4.911

Review 3.  Impact of the Health Insurance Portability and Accountability Act on participant recruitment and retention.

Authors:  Deidre D Wipke-Tevis; Melissa A Pickett
Journal:  West J Nurs Res       Date:  2007-06-05       Impact factor: 1.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.